Should we routinely measure a proxy for insulin resistance as well as improve our modelling techniques to better predict the likelihood of coronary heart disease in people with type 2 diabetes? For debate

MeSH terms

• Coronary Disease / prevention & control*
• Diabetes Mellitus, Type 2 / prevention & control*
• Diabetic Angiopathies / prevention & control*
• Humans
• Insulin Resistance / physiology*
• Models, Cardiovascular
• Regression Analysis
• Risk Assessment
• Risk Factors